trial · primary record
Navlimetostat
Pancreatic Ductal Adenocarcinoma (PDAC)
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 18 |
| Primary completion | 2031-06-30 |
| Primary endpoint | Incidence of Adverse Events |
| Registry ID | NCT07905131 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:32:49.519Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07905131
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.